BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/95/0.1/21.03.25 | Delayed Börse Stuttgart 02:16:45 2024-07-01 EDT | ||
| 0.94 EUR | -6.93% |
|
| Current month | -6.93% | ||
| 1 month | +28.77% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-01 | 0.94 | -6.93% |
| 24-06-28 | 1.01 | +16.09% |
| 24-06-27 | 0.87 | -3.33% |
| 24-06-26 | 0.9 | +7.14% |
| 24-06-25 | 0.84 | -6.67% |
Delayed Quote Börse Stuttgart
Last update July 01, 2024 at 02:16 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD49BP |
| ISIN | DE000VD49BP8 |
| Date issued | 2024-04-29 |
| Strike | 95 $ |
| Maturity | 2025-03-21 (262 Days) |
| Parity | 10 : 1 |
| Emission price | 0.73 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.01 € |
|---|---|
| Lowest since issue | 0.62 € |
| Spread | 0.02 € |
| Spread % | 2.22% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.25
USD
Average target price
96.05
USD
Spread / Average Target
+6.43%
- Stock Market
- Warrants
- Warrant
